Certified SPRAVATO™ Treatment Center
We proudly offer SPRAVATO™ services in collaboration with Greenbrook TMS, housed within our facility to provide advanced care for treatment-resistant depression.
What is SPRAVATO™?
SPRAVATO™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults.
For additional safety information please visit SPRAVATO’s official website.
We outsource our SPRAVATO™ services to Greenbrook TMS, conveniently located within our facility.
Why SPRAVATO®?
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).
It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.
Proven Effective for Treatment-Resistant Depression
You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).
Adults with treatment-resistant depression who were part of a clinical study were given either a nasal esketamine spray or a placebo spray.
Those who added esketamine, the active ingredient in SPRAVATO®, to their oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.*
*Based on an overall score on a standardized rating scale.
- Choosing a selection results in a full page refresh.